Literature DB >> 35365442

[TIM-3 gene is highly expressed in ephithelial ovarian cancer to promote proliferation and migration of ovarian cancer cells].

Y Huo1,2, Y Wang3, N An3, X DU1.   

Abstract

OBJECTIVE: To analyze the expression of immunoglobulin mucin molecule 3 (TIM-3) in epithelial ovarian cancer (EOC) and the effects of TIM-3 knockdown and overexpression on proliferation and migration of ovarian cancer cells.
METHODS: We analyzed TIM-3 expression in EOC and normal ovarian tissues using GEPIA database. We also detected TIM-3 expression levels in 82 surgical specimens of EOC and 18 specimens of normal ovarian tissues using immunohistochemistry, and analyzed the correlation of TIM-3 expression with clinicopathological parameters and survival outcomes of the patients. The expression of TIM-3 and Wnt1 mRNA in the tissues were detected using qRT-PCR. We constructed SKOV3 cell models of TIM-3 knockdown and overexpression and examined the changes in proliferation, apoptosis, migration and invasion of the cells using MTT assay, Annexin V-FITC/PI staining, scratch test and Transwell assay. The activity of Wnt/β-catenin pathway in the transfected was detected using dual luciferase reporter assay, and the mRNA levels of TCF-7, TCCFL-2 and CD44 were detected using qPCR. The protein expressions of MMP-9, CD44, Wnt1, β-catenin and E-cad in the transfected cells were detected with Western blotting.
RESULTS: The positive expression rate of TIM-3 was significantly higher in EOC tissues than in normal ovarian tissues (P < 0.05). The expression of TIM-3 was significantly correlated with FIGO stage, histological differentiation and lymph node metastasis, and was positively correlated with Wnt1 level (P < 0.05). In SKOV3 cells, TIM-3 knockdown significantly lowered the activity of Wnt/ β-catenin pathway, inhibited cell proliferation, migration and invasion, and promoted cell apoptosis. TIM-3 knockdown significantly down-regulated the mRNA levels of TCF-7, TCFL-2 and CD44 and the protein levels of MMP-9, CD44, Wnt1 and β-catenin, and significantly up-regulated the expression level of E-cad (P < 0.05). Overexpression of TIM-3 caused opposite effects in SKOV3 cells.
CONCLUSION: TIM-3 is highly expressed in EOC tissue to promote malignant behaviors of the tumor cells possibly by activating the Wnt/β-catenin signal pathway.

Entities:  

Keywords:  GEPIA database; TIM-3 gene; Wnt/β-catenin signaling pathway; biological behaviors; epithelial ovarian cancer

Mesh:

Substances:

Year:  2022        PMID: 35365442      PMCID: PMC8983363          DOI: 10.12122/j.issn.1673-4254.2022.02.04

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  16 in total

1.  Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.

Authors:  Jie Wang; Han Cai; Qiaoli Liu; Yue Xia; LiKai Xing; Qingsong Zuo; Yong Zhang; Cao Chen; Ke Xu; Peihao Yin; Teng Chen
Journal:  Am J Chin Med       Date:  2020-04-24       Impact factor: 4.667

Review 2.  Molecular basis of the effect of MMP-9 on the prostate bone metastasis: A review.

Authors:  Emilio Rubén Pego; Isaac Fernández; María Jesús Núñez
Journal:  Urol Oncol       Date:  2018-04-09       Impact factor: 3.498

3.  [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].

Authors:  Peng Ji; Dikang Chen; Jianye Bian; Rui Xia; Xinyu Song; Wen Wen; Xueguang Zhang; Yibei Zhu
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2015-06

4.  PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.

Authors:  Masaaki Sawada; Kumiko Goto; Akiko Morimoto-Okazawa; Miya Haruna; Kei Yamamoto; Yoko Yamamoto; Satoshi Nakagawa; Kosuke Hiramatsu; Shinya Matsuzaki; Eiji Kobayashi; Atsunari Kawashima; Michinari Hirata; Kota Iwahori; Toshihiro Kimura; Yutaka Ueda; Tadashi Kimura; Hisashi Wada
Journal:  Int Immunol       Date:  2020-05-30       Impact factor: 4.823

5.  Protumorigenic role of Timeless in hepatocellular carcinoma.

Authors:  Nahla Elgohary; Rossella Pellegrino; Olaf Neumann; Heba M Elzawahry; Magdy M Saber; Ahmed A Zeeneldin; Robert Geffers; Volker Ehemann; Peter Schemmer; Peter Schirmacher; Thomas Longerich
Journal:  Int J Oncol       Date:  2014-11-14       Impact factor: 5.650

6.  [Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].

Authors:  Shi-Peng Gong; Yong-Ning Chen; Ya-di Zhang; Wei Yao; Li Chen; Shi-San Liu; Huan Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

7.  Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.

Authors:  Ila Datar; Miguel F Sanmamed; Jun Wang; Brian S Henick; Jungmin Choi; Ti Badri; Weilai Dong; Nikita Mani; Maria Toki; Luis D Mejías; Maria D Lozano; Jose Luis Perez-Gracia; Vamsidhar Velcheti; Matthew D Hellmann; Justin F Gainor; Kristen McEachern; David Jenkins; Konstantinos Syrigos; Katerina Politi; Scott Gettinger; David L Rimm; Roy S Herbst; Ignacio Melero; Lieping Chen; Kurt A Schalper
Journal:  Clin Cancer Res       Date:  2019-05-03       Impact factor: 12.531

Review 8.  Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.

Authors:  Qi-Ping Hu; Jing-Ya Kuang; Qing-Kai Yang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Int J Cancer       Date:  2016-01-07       Impact factor: 7.396

9.  [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].

Authors:  H Wang; X Chen; Y Chen; Y Cao; Y Chen; G Liu; L Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

10.  Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status.

Authors:  Junlong Wu; Guowen Lin; Yao Zhu; Hailiang Zhang; Guohai Shi; Yijun Shen; Yiping Zhu; Bo Dai; Dingwei Ye
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.